These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8738959)

  • 1. NOD mouse diabetes: the ubiquitous mouse hsp60 is a beta-cell target antigen of autoimmune T cells.
    Birk OS; Elias D; Weiss AS; Rosen A; van-der Zee R; Walker MD; Cohen IR
    J Autoimmun; 1996 Apr; 9(2):159-66. PubMed ID: 8738959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of spontaneous autoimmune diabetes in NOD mice by quantification of autoreactive T cells in peripheral blood.
    Trudeau JD; Kelly-Smith C; Verchere CB; Elliott JF; Dutz JP; Finegood DT; Santamaria P; Tan R
    J Clin Invest; 2003 Jan; 111(2):217-23. PubMed ID: 12531877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An antigen-specific immunotherapeutic, AKS-107, deletes insulin-specific B cells and prevents murine autoimmune diabetes.
    Alleva DG; Delpero AR; Sathiyaseelan T; Murikipudi S; Lancaster TM; Atkinson MA; Wasserfall CH; Yu L; Ragupathy R; Bonami RH; Zion TC
    Front Immunol; 2024; 15():1367514. PubMed ID: 38515750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin B-chain hybrid peptides are agonists for T cells reactive to insulin B:9-23 in autoimmune diabetes.
    Wenzlau JM; DiLisio JE; Barbour G; Dang M; Hohenstein AC; Nakayama M; Delong T; Baker RL; Haskins K
    Front Immunol; 2022; 13():926650. PubMed ID: 36032090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. γδ T cells recognize the insulin B:9-23 peptide antigen when it is dimerized through thiol oxidation.
    Aydintug MK; Zhang L; Wang C; Liang D; Wands JM; Michels AW; Hirsch B; Day BJ; Zhang G; Sun D; Eisenbarth GS; O'Brien RL; Born WK
    Mol Immunol; 2014 Aug; 60(2):116-28. PubMed ID: 24853397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene therapy for type 1 diabetes: a novel approach for targeted treatment of autoimmunity.
    Creusot RJ; Fathman CG
    J Clin Invest; 2004 Oct; 114(7):892-4. PubMed ID: 15467826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein kinase A-catalyzed phosphorylation of heat shock protein 60 chaperone regulates its attachment to histone 2B in the T lymphocyte plasma membrane.
    Khan IU; Wallin R; Gupta RS; Kammer GM
    Proc Natl Acad Sci U S A; 1998 Sep; 95(18):10425-30. PubMed ID: 9724719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigen-based immune therapeutics for type 1 diabetes: magic bullets or ordinary blanks?
    Culina S; Boitard C; Mallone R
    Clin Dev Immunol; 2011; 2011():286248. PubMed ID: 21647401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HSP60: a double edge sword in autoimmunity.
    Landstein D; Ulmansky R; Naparstek Y
    Oncotarget; 2015 Oct; 6(32):32299-300. PubMed ID: 26431161
    [No Abstract]   [Full Text] [Related]  

  • 10. Pathogenic Autoimmunity in Atherosclerosis Evolves from HSP60-Reactive CD4 + T Cells.
    Wang S; Chen Y; Zhou D; Zhang J; Guo G; Chen Y
    J Cardiovasc Transl Res; 2024 May; ():. PubMed ID: 38767798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noncontiguous T cell epitopes in autoimmune diabetes: From mice to men and back again.
    Amdare N; Purcell AW; DiLorenzo TP
    J Biol Chem; 2021 Jul; 297(1):100827. PubMed ID: 34044020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Heat Shock Proteins in Type 1 Diabetes.
    Moin ASM; Nandakumar M; Diane A; Dehbi M; Butler AE
    Front Immunol; 2020; 11():612584. PubMed ID: 33584694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heat shock proteins (HSPs) in the homeostasis of regulatory T cells (Tregs).
    Koliński T; Marek-Trzonkowska N; Trzonkowski P; Siebert J
    Cent Eur J Immunol; 2016; 41(3):317-323. PubMed ID: 27833451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does Hsp60 Provide a Link between Mitochondrial Stress and Inflammation in Diabetes Mellitus?
    Juwono J; Martinus RD
    J Diabetes Res; 2016; 2016():8017571. PubMed ID: 27478851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of Adjuvant Arthritis by Cellular and Humoral Immunity to Hsp65.
    Kim EY; Durai M; Mia Y; Kim HR; Moudgil KD
    Front Immunol; 2016; 7():203. PubMed ID: 27379088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New strategy for testing efficacy of immunotherapeutic compounds for diabetes in vitro.
    Pileggi GS; Clemencio AD; Malardo T; Antonini SR; Bonato VL; Rios WM; Silva CL
    BMC Biotechnol; 2016 May; 16(1):40. PubMed ID: 27165305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The importance of the Non Obese Diabetic (NOD) mouse model in autoimmune diabetes.
    Pearson JA; Wong FS; Wen L
    J Autoimmun; 2016 Jan; 66():76-88. PubMed ID: 26403950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inducing immune tolerance: a focus on Type 1 diabetes mellitus.
    Xu D; Prasad S; Miller SD
    Diabetes Manag (Lond); 2013 Sep; 3(5):415-426. PubMed ID: 24505231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel autoantigens in type 1 diabetes.
    Han S; Donelan W; Wang H; Reeves W; Yang LJ
    Am J Transl Res; 2013; 5(4):379-92. PubMed ID: 23724162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heat shock protein bystander antigens for peptide immunotherapy in autoimmune disease.
    Zonneveld-Huijssoon E; Albani S; Prakken BJ; van Wijk F
    Clin Exp Immunol; 2013 Jan; 171(1):20-9. PubMed ID: 23199319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.